Risk-Based Monitoring
-
$279
Identifying Workforce Gaps Post Risk-Based Monitoring (RBM): It’s Time to “DIG” in!Sandra “SAM” SatherOn-Demand -
$279
New FDA Draft Guidance: A Risk-Based Approach to Monitoring Clinical InvestigationsSandra “SAM” SatherOn-Demand -
$1199
-
$279
Investigator Oversight Plans: Essentials for Inspection Readiness Post ICH GCP E6 (R2) AddendumSandra “SAM” SatherOn-Demand -
$279
-
$279
-
$279
-
$279
FINAL Risk-based Monitoring Guidance: Updates, Impact & Analysis on Clinical Monitoring SystemsSandra “SAM” SatherOn-demand -
$279